Sangmin Lee, MD

Sangmin Lee, MD Specialties: Hematology-Oncology, Medical Oncology, Hematology

Sangmin Lee, MD
Specialties: Hematology-Oncology, Medical Oncology, Hematology
phone icon
checkmark iconAccepting new patients
"

Address

520 East 70th Street
New York, NY 10021
US

insurance iconinsurance icon
Insurances Accepted

Please contact the doctor's office to verify that your insurance is accepted.

  • AETNA
  • Affinity
  • CIGNA
  • Emblem Select Care
  • EmblemHealth HIP
  • Empire Blue Cross Blue Shield
  • Empire Blue Cross Blue Shield Healthplus
  • Fidelis Care
  • Group Health Incorporated
  • Healthfirst
  • Medicaid
  • Medicare
  • Oxford Health Plans
  • POMCO
  • Rockefeller University - CoreSource
  • United Empire
  • UnitedHealthcare
  • VNSNY CHOICE

about iconabout icon
About Sangmin Lee, MD

Sangmin Lee, MD, is an Assistant Professor of Medicine at Weill Cornell Medical College and Assistant Attending Physician at the NewYork-Presbyterian Hospital. After obtaining a BA/MS as a Vagelos Scholar in Molecular Life Sciences at the University of Pennsylvania in 2003, Dr. Lee received his MD from the University of Miami in 2007.  Following his internal medicine residency at the University of Alabama at Birmingham, he completed his fellowship in hematology and oncology at the New York Presbyterian Hospital/Columbia University Medical Center from 2010-2013 where he focused on epigenetics of myelodysplastic syndromes (MDS) under Drs. Azra Raza and Benjamin Tycko.   In July 2013, Dr. Lee was recruited to serve in the Leukemia Program in the Division of Hematology & Medical Oncology.  At Weill Cornell, he has served as an Edward P. Evans Fellow in the multi-institutional MDS Clinical Research Consortium, focusing on development of clinical and translational research programs in MDS, as well as other hematologic malignancies.  He is currently the principal investigator on clinical trials investigating new therapeutic approaches in elderly AML patients, and is an investigator on a number of clinical trials for MDS, AML, and other myeloproliferative neoplams.  He is the principal investigator for translational studies focusing on characterization of mutational and epigenetic profiling of MDS and AML, in collaboration with scientists at Weill Cornell Medicine.Dr. Lee has publications in the Clinical Cancer Research, and Journal of Blood Medicine, among others.  He is a member of the American Society of Clinical Oncology, the American Society of Hematology, and the American Association for Cancer Research.


Hospital Affiliations

  • NewYork-Presbyterian / Weill Cornell Medical Center

Expertise

  • Acute Lymphocytic Leukemia (ALL)

  • Aplastic Anemia

  • Chronic Myelogenous Leukemia

  • Immunotherapy

  • Myelodysplastic Disease

  • Myelodysplastic Syndrome

  • Myeloproliferative Disease

Education

  • Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center
  • Internship: University of Alabama at Birmingham Hospital
  • Medical School: University of Miami - Miller School of Medicine
  • Residency: University of Alabama at Birmingham Hospital

Board Certifications

  • Hematology
  • Internal Medicine
  • Medical Oncology

Languages Spoken

  • Korean